Obesity Trial, Recruiting (NCT06363253)

Obesity Trial, Recruiting NCT06363253 Sponsor: Sengkang General Hospital Condition: Obesity

Printed from Voxsanity (voxsanity.com.au) — NCT06363253 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Obesity

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People with a Body Mass Index (BMI) over 27.5, which is a measure of body weight relative to height that falls in the obese range (obese group)
People with sarcopenia, which means having low muscle strength (weak grip strength — below 26kg for men or below 18kg for women), and/or slow walking speed (below 0.8 metres per second), combined with low muscle mass (below 7.0kg/m² for men or below 5.7kg/m² for women) (sarcopenic group)
Healthy people who do not have sarcopenia and whose BMI is below 27.5 (control group)

Who may not be able to join:

People who are not willing or able to give formal written consent to take part in the study
People who have an intestinal stoma (a surgically created opening in the abdomen for waste to leave the body), because stool samples would not be able to be collected

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 14 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 69305000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06363253

Sponsor: Sengkang General Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Obesity

Trial contact: 69305000

More information: https://clinicaltrials.gov/study/NCT06363253

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People with a Body Mass Index (BMI) over 27.5, which is a measure of body weight relative to height that falls in the obese range (obese group)
People with sarcopenia, which means having low muscle strength (weak grip strength — below 26kg for men or below 18kg for women), and/or slow walking speed (below 0.8 metres per second), combined with low muscle mass (below 7.0kg/m² for men or below 5.7kg/m² for women) (sarcopenic group)
Healthy people who do not have sarcopenia and whose BMI is below 27.5 (control group)

Who may not be able to join:

People who are not willing or able to give formal written consent to take part in the study
People who have an intestinal stoma (a surgically created opening in the abdomen for waste to leave the body), because stool samples would not be able to be collected

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 14 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Sengkang General Hospital

Registry

ClinicalTrials.gov

Start date

14 August 2023

Est. completion

31 December 2026

Where this trial is recruiting

🇸🇬 Singapore

Primary endpoints

Metagenomic alterations; Metabolomic alterations

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov